Can negative pressure therapy disrupt renal support in heart failure? Inside JuxtaFlow’s new approach

Can negative pressure therapy disrupt renal support in heart failure? Inside JuxtaFlow’s new approach

Roivios Ltd., a clinical-stage medical device developer focused on kidney health, has reported promising results from its first-in-human trial of the JuxtaFlow Renal Assist Device. This investigational system applies controlled negative pressure to the renal pelvis to enhance urine output and sodium excretion in patients with diuretic-resistant cardiorenal syndrome and acute decompensated heart failure. While […]

Can Roivios’ JuxtaFlow device redefine kidney support in heart failure and cardiac surgery patients?

Can Roivios’ JuxtaFlow device redefine kidney support in heart failure and cardiac surgery patients?

Roivios Ltd., a clinical-stage medical device developer, has announced encouraging results from its first-in-human study of the JuxtaFlow Renal Assist Device, a technology designed to support fluid removal and renal function in patients with diuretic-resistant cardiorenal syndrome and acute decompensated heart failure. The results, published in the ASAIO Journal, showed that JuxtaFlow significantly improved both […]